This coincides with the reports from Harmey et al.whereby PAPP-A resistant IGFBP-4 led to reduced lung metastasis in mice – indicating the role of PAPP-A as an oncogenic factor for BC in vivo [17, 99]. This evidence concerns the gene IGFBP4 and breast cancer.